SUDARSHAN PHARMA INDUSTRIES
Back to Balance Sheet
|
SUDARSHAN PHARMA INDUSTRIES Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹160 Cr | ₹123 Cr | ₹82 Cr | ₹73 Cr | ₹60 Cr |
What is the latest Sundry Debtors ratio of SUDARSHAN PHARMA INDUSTRIES ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹160 Cr |
| Mar2024 | ₹123 Cr |
| Mar2023 | ₹82 Cr |
| Mar2022 | ₹73 Cr |
| Mar2021 | ₹60 Cr |
How is Sundry Debtors of SUDARSHAN PHARMA INDUSTRIES Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹160 Cr | 30.69 | |
| Mar2024 | ₹123 Cr | 50.35 | |
| Mar2023 | ₹82 Cr | 10.93 | |
| Mar2022 | ₹73 Cr | 21.66 | |
| Mar2021 | ₹60 Cr | - | |
Compare Sundry Debtors of peers of SUDARSHAN PHARMA INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUDARSHAN PHARMA INDUSTRIES | ₹973.5 Cr | -4% | -4.2% | 34.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,478.0 Cr | -0.2% | -3.2% | 12.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹253,031.0 Cr | 2% | 5.3% | 57.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,216.0 Cr | -2.4% | -3.1% | 36.4% | Stock Analytics | |
| CIPLA | ₹112,205.0 Cr | 0.6% | -2.2% | -9.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,040.0 Cr | 0.9% | 4% | -7.6% | Stock Analytics | |
SUDARSHAN PHARMA INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUDARSHAN PHARMA INDUSTRIES | -4% |
-4.2% |
34.9% |
| SENSEX | -2.8% |
-6.1% |
-11.9% |
You may also like the below Video Courses